Impaired fatty acid uptake in ischemic but viable myocardium identified by thallium-201 reinjection

American Heart Journal

Volumn 131, Issue 3, 1996, Pages 458-465

  Matsunari, Ichiro ^a,c   Fujino, Susumu ^a   Taki, Junichi ^b   Senma, Junji ^a   Aoyama, Takahiko ^a   Wakasugi, Takanobu ^a   Hirai, Jun Ichi ^a   Saga, Takashi ^a   Ichiyanagi, Kenji ^a   Hisada, Kinichi ^b  

^a Fukui Prefectural Hospital   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 123; THALLIUM 201;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; EXERCISE TEST; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 13344280352     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90523-2     Document Type: Article

References (29)

1. Goodman MM, Kirsch G, Knapp FF Jr. Synthesis and evaluation of radioiodinated terminal p-iodo-phenyl-substituted α- and β-methyl-branched fatty acids. J Med Chem 1984;27:390-7.
2. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986;12:S39-44.
3. 131I)-iodophenyl-β-methylpentadecanoic acid in normotensive and hypertensive rats. J Nucl Med 1986;27:1178-83.
4. Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N, Kawai H, Kaneko M. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992;33:6-13.
5. 201Tl. Nucl Med Commun 1993;14:181-8.
6. Dudczak R, Schmoliner R, Angelberger P, Knapp FF, Goodman MM. Structurally modified fatty acids: clinical potential as tracers of metabolism. Eur J Nucl Med 1986;12:S45-8.
7. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, Nohara R, Kambara H, Kawai C, Ikekubo K, Kato H. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-67.
8. Matsunari I, Saga T, Taki J, Akashi Y, Hirai J, Wakasugi T, Aoyama T, Matoba M, Ichiyanagi K, Hisada K. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994;35:1279-85.
9. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
10. Rocco TP, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 1990;66:158-63.
11. Tamaki N, Ohtani H, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J. Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med 1990;31:1617-23.
12. Ohtani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, Konishi J. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990;66:394-9.
13. 18F-fluorodeoxyglucose. Circulation 1991;83:26-37.
14. Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991;32:673-8.
15. Opie LH. Metabolism of the heart in health and disease. AM HEART J 1968;76:685.
16. Dilsizian V, Freedman NMT, Bacharach SL, Perrone-Filardi P, Bonow RO. Regional thallium uptake in irreversible defects: magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992;85:627-34.
17. 11C-palmitate. Circulation 1977;55:853-7.
18. Schon HR, Schelbert HR, Robinson G, Najafi A, Huang SC, Hansen H, Barrio J, Kuhl DE, Phelps ME. C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C-11 palmitic acid in normal myocardium. AM HEART J 1982;103:532-47.
19. Schon HR, Schelbert HR, Najafi A, Hansen H, Huang H, Barrio J, Phelps ME. C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II. Kinetics of C-11 palmitic acid in acutely ischemic myocardium. AM HEART J 1982;103:548-61.
20. Schelbert HR, Henze E, Schon HR, Keen R, Hansen H, Selin C, Huang SC, Barrio JR, Phelps ME. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. AM HEART J 1983;105:492-504.
21. Machulla HJ, Marsmann M, Dutschka K. Biochemical concepts and synthesis of radioiodinated phenyl fatty acid for in vivo metabolic studies of the myocardium. Eur J Nucl Med 1980;5:171-3.
22. Relias JS, Corbett JR, Kulkarni P, Morgan C, Devous MD, Buja LM, Bush L, Parkey RW, Willerson JT, Lewis SE. Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography. Am J Cardiol 1983;52:1326-32.
23. Vyska K, Machulla HJ, Stremmel W, Fassbender D, Knapp WH, Notohamiprodjo G, Gleichmann U, Meyer H, Knust EJ, Korfer R. Regional myocardial free fatty acid extraction in normal and ischemic myocardium. Circulation 1988;78:1218-33.
24. Yonekura Y, Brill AB, Som P, Yamamoto K, Srivastava SC, Iwai J, Elmaleh DR, Livini E, Strauss HW, Goodman MM, Knapp FF Jr. Regional myocardial substrate uptake in hypertensive rats: a quantitative autoradiographic measurement. Science 1985;227:1494-6.
25. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Magata Y, Torizuka T, Tadamura E, Nahara R, Sasayama S, Konishi J. Assessment of fatty acid metabolism using I-123 branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 1993;7:SII 41-7.
26. Fox KAA, Abendschein DR, Ambos HD, Sobel BE, Bergmann SR. Efflux of metabolized and non-metabolized fatty acid from canine myocardium. Circ Res 1985;57:232-43.
27. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989;32:217-38.
28. Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NMT, Bonow RO. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium: comparison with metabolic activity by positron emission tomography. Circulation 1993; 88:941-52.
29. 123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating myocardial fatty acid metabolism. Kakuigaku 1992;29:305-17 [in Japanese].